Going concern and liquidity shortfall
Management disclosed substantial doubt about the ability to continue as a going concern and said the company needs additional capital to fund operations and repay debts.
- Scope
- Entire business
- Materiality
- high
Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. is a Colorado-based company that has repositioned itself around medical cannabis education, clinical research services, and cannabidiol product development. It operates through three main businesses: Pharmacology University for cannabis-related education and consulting, Alpha Research Institute for clinical trials and research services, and a planned CBD product line under the VitaCookies name. The company also describes an intellectual property portfolio that includes patent applications, trademarks, and medical formulations tied to cannabis and biotechnology applications. Its business model is early-stage and capital constrained, with management explicitly stating that continued operations depend on raising funding and growing revenue from these activities.
86,8 %
−181,1 %
+21,8 %
0.03
0.03
| % | |
|---|---|
| Medical cannabis education | 45% Courses, seminars, certification programs, and training content for physicians, industry workers, and the public. |
| Clinical research services | 35% Sponsor and CRO services for clinical trials, including studies that may involve cannabis and CBD products. |
| CBD products | 15% Planned manufacture, marketing, and sale of cannabidiol-based consumer products under VitaCookies. |
| Publishing, consulting, and franchising | 5% Digital publishing, marketing support, consulting, and franchise-related activities tied to medical cannabis education. |
The company sells primarily to participants in the medical cannabis ecosystem rather than to a broad consumer base...
- Physicians and healthcare professionalsprimary
Buy certification courses and seminars focused on medical cannabis, clinical use, and related legal/ethical issues.
- Cannabis industry workersprimary
Purchase training and certification to support operational knowledge, compliance, and professional development.
- Clinical research sponsors and third partiesprimary
Engage Alpha Research Institute for clinical trial services and research execution in therapeutic areas.
- General public and online learnerssecondary
Buy educational materials and seminars covering cannabis history, medicinal value, and industry basics.
- CBD consumersemerging
Potential buyers of VitaCookies cannabidiol products once commercialized.
The company is headquartered in the United States and repeatedly describes its education business as serving the U.S...
- •Headquartered in the United States
- •Education business serves the U.S. market and Latin America
- •Online education extends reach worldwide
- •Clinical research and CBD plans are tied to U.S. cannabis regulation
- •Geography is driven more by legal access than by manufacturing footprint
Management’s strategy is to build a niche position in medical cannabis science by combining education, clinical...
01
Commercialize VitaCookies CBD productsshort-term
The company believes product sales could create a new revenue stream and help move it toward profitability.
02
Expand medical cannabis education and certificationshort-term
Education is a core operating business and can be scaled through online delivery and seminars.
03
Grow clinical research and CRO servicesmedium-term
Clinical trials provide service revenue and reinforce the company’s scientific positioning.
04
Build intellectual property and regulatory credibilitymedium-term
Patents, trademarks, and policy participation may support differentiation and market legitimacy.
The company is highly exposed to going-concern and financing risk because management states it needs substantial...
Dependence on cannabis regulation and DEA policy
Education, research, and CBD commercialization all depend on legal access to cannabis/hemp and on the pace of federal regulatory change.
- Scope
- U.S. cannabis research and CBD commercialization
- Materiality
- high
Revenue concentration and project timing
Clinical trial revenue can change sharply based on the number and timing of contracts in a quarter.
- Scope
- Alpha Research Institute
- Materiality
- medium
Dilution from equity financing
Management indicated future funding may come from private sales of common stock or convertible securities at discounts.
- Scope
- Shareholders
- Materiality
- high
Revenue recognition
Clinical trial contracts and education sales
Share-based compensation
Operating loss and net loss
Debt discounts and derivative liabilities
Net loss and comparability across periods
Going concern disclosures and estimates
Balance sheet and earnings quality
BioScience Health Innovations, Inc.
BHIC · Services-Computer Processing & Data Preparation
HARVARD BIOSCIENCE INC
HBIO · Laboratory Analytical Instruments
Harvard Bioscience designs, manufactures, and sells life-science research tools used in drug discovery, translational medicine, and preclinical testing.
CANNAPHARMARX, INC.
CPMD · Pharmaceutical Preparations
CV Sciences, Inc.
CVSI · Pharmaceutical Preparations
Charlie's Holdings, Inc.
CHUC · Medicinal Chemicals & Botanical Products
Bespoke Extracts, Inc.
BSPK · Pharmaceutical Preparations
: 28/04/2026